Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01CA065746-02
Application #
2108858
Study Section
Special Emphasis Panel (SRC (04))
Project Start
1995-02-01
Project End
1996-09-30
Budget Start
1995-12-01
Budget End
1996-09-30
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Rayala, Suresh K; Kumar, Rakesh (2007) Sliding p21-activated kinase 1 to nucleus impacts tamoxifen sensitivity. Biomed Pharmacother 61:408-11
Manavathi, Bramanandam; Singh, Kamini; Kumar, Rakesh (2007) MTA family of coregulators in nuclear receptor biology and pathology. Nucl Recept Signal 5:e010
Ohshiro, Kazufumi; Rayala, Suresh K; Kondo, Seiji et al. (2007) Identifying the estrogen receptor coactivator PELP1 in autophagosomes. Cancer Res 67:8164-71
Singh, Rajesh R; Kumar, Rakesh (2007) MTA family of transcriptional metaregulators in mammary gland morphogenesis and breast cancer. J Mammary Gland Biol Neoplasia 12:115-25
Barnes, Christopher J; Ohshiro, Kazufumi; Rayala, Suresh K et al. (2007) Insulin-like growth factor receptor as a therapeutic target in head and neck cancer. Clin Cancer Res 13:4291-9
Rayala, Suresh K; Martin, Emil; Sharina, Iraida G et al. (2007) Dynamic interplay between nitration and phosphorylation of tubulin cofactor B in the control of microtubule dynamics. Proc Natl Acad Sci U S A 104:19470-5
Manavathi, Bramanandam; Rayala, Suresh K; Kumar, Rakesh (2007) Phosphorylation-dependent regulation of stability and transforming potential of ETS transcriptional factor ESE-1 by p21-activated kinase 1. J Biol Chem 282:19820-30
den Hollander, Petra; Rayala, Suresh K; Coverley, Dawn et al. (2006) Ciz1, a Novel DNA-binding coactivator of the estrogen receptor alpha, confers hypersensitivity to estrogen action. Cancer Res 66:11021-9
Rayala, Suresh K; Molli, Poonam R; Kumar, Rakesh (2006) Nuclear p21-activated kinase 1 in breast cancer packs off tamoxifen sensitivity. Cancer Res 66:5985-8
Wang, R-A; Zhang, H; Balasenthil, S et al. (2006) PAK1 hyperactivation is sufficient for mammary gland tumor formation. Oncogene 25:2931-6

Showing the most recent 10 out of 63 publications